History
  • No items yet
midpage
United States v. Terry Schwarck
719 F.3d 921
8th Cir.
2013
Read the full case

Background

  • Schwarck was convicted by a jury of conspiracy to distribute and possess with intent to distribute 500 grams or more of methamphetamine.
  • The district court sentenced Schwarck to 240 months’ imprisonment.
  • Undercover officer Ripley investigated Schwarck and testified about two meth transactions involving Christine Snyder.
  • Schwarck argued he was a user, not a dealer; the government admitted Koepke as an expert on meth distribution methods.
  • Koepke described dealer practices (security cameras, RF detectors, using a trusted helper, currency patterns) to link to Schwarck’s activities.
  • Schwarck timely appealed, challenging Koepke’s testimony as improper under Rule 702/Daubert and its prejudicial impact.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Koepke’s expert testimony was properly admitted Schwarck contends it was irrelevant and prejudicial. Government argues it explained meth distribution MO and aided the defense. Admission was not an abuse of discretion; it aided understanding of trafficking.
Whether Koepke’s testimony was cumulative Koepke’s testimony duplicated other witnesses’ evidence. Testimony added unique explanatory value about drug trade. Not unduly cumulative; not unfairly prejudicial given probative value.
Whether Koepke’s testimony impermissibly invoked a drug courier profile Koepke’s testimony resembles prohibited courier-profile evidence. Testimony rebutted defendant’s defense and elucidated drug trade practices. Permissible as relevant to the defense and not an impermissible profile.

Key Cases Cited

  • United States v. Spencer, 700 F.3d 317 (8th Cir. 2012) (test for admissibility of expert testimony under Rule 702)
  • United States v. Molina, 172 F.3d 1048 (8th Cir. 1999) (experts may testify on MO of drug dealers)
  • Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579 (Supreme Ct. 1993) (reliability and relevance gatekeeper for expert testimony)
  • United States v. Carter, 901 F.2d 683 (8th Cir. 1990) (courier-profile evidence not allowed as substantive proof)
  • United States v. Hernandez-Cuartas, 717 F.2d 552 (11th Cir. 1983) (cites concerns about profile-type evidence)
  • United States v. Ortega, 150 F.3d 937 (8th Cir. 1998) (admissibility of expert testimony explaining drug trade)
  • United States v. Brown, 110 F.3d 605 (8th Cir. 1997) (MO explanations to juries)
  • United States v. Jeanetta, 533 F.3d 651 (8th Cir. 2008) (context for expert explanations of drug operations)
  • United States v. Rosa-Carino, 615 F.3d 75 (1st Cir. 2010) (distinguishes permissible explanatory testimony from profile evidence)
  • United States v. Demery, 674 F.3d 776 (8th Cir. 2011) (harmlessness of cumulative evidence; Daubert considerations)
  • United States v. Coleman, 584 F.3d 1121 (8th Cir. 2009) (standard for abuse of discretion in evidentiary rulings)
Read the full case

Case Details

Case Name: United States v. Terry Schwarck
Court Name: Court of Appeals for the Eighth Circuit
Date Published: Jun 28, 2013
Citation: 719 F.3d 921
Docket Number: 12-2054
Court Abbreviation: 8th Cir.